Latest & greatest articles for dementia

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on dementia or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on dementia and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for dementia

401. Discontinuation of antidepressants in people with dementia and neuropsychiatric symptoms (DESEP study): double blind, randomised, parallel group, placebo controlled trial. Full Text available with Trip Pro

Discontinuation of antidepressants in people with dementia and neuropsychiatric symptoms (DESEP study): double blind, randomised, parallel group, placebo controlled trial. To determine the effect of discontinuing antidepressant treatment in people with dementia and neuropsychiatric symptoms.Double blind, randomised, parallel group, placebo controlled trial.Norwegian nursing homes; residents recruited by 16 study centres in Norway from August 2008 to June 2010.128 patients with Alzheimer's (...) disease, dementia or vascular dementia, and neuropsychiatric symptoms (but no depressive disorder), who had been prescribed escitalopram, citalopram, sertraline, or paroxetine for three months or more. We excluded patients with severe somatic disease or terminal illness, or who were unable to take tablets or capsules as prescribed.Antidepressant treatment was discontinued over one week in 63 patients, and continued in 68 patients. We assessed patients at baseline, four, seven, 13, and 25 weeks.Primary

2012 BMJ Controlled trial quality: predicted high

402. [Positron emission tomography in combination with computed tomography (PET/CT) in minimal cognitive impairment and dementias]

[Positron emission tomography in combination with computed tomography (PET/CT) in minimal cognitive impairment and dementias] Tomografía por emisión de positrones combinada con tomografía computada (PET/TC) en deterioro cognitivo mínimo y demencias [Positron emission tomography in combination with computed tomography (PET/CT) in minimal cognitive impairment and dementias] Tomografía por emisión de positrones combinada con tomografía computada (PET/TC) en deterioro cognitivo mínimo y demencias (...) [Positron emission tomography in combination with computed tomography (PET/CT) in minimal cognitive impairment and dementias] Pichon Riviere A, Augustovski F, Garcia Marti S, Glujovsky D, Alcaraz A, Lopez A, Bardach A, Ciapponi A, Rey-Ares L, Rojas J Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Pichon Riviere A, Augustovski F, Garcia Marti S

2012 Health Technology Assessment (HTA) Database.

403. Is MRI better than CT for detecting a vascular component to dementia? A systematic review and meta-analysis

Is MRI better than CT for detecting a vascular component to dementia? A systematic review and meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2012 DARE.

404. Effectiveness of case management among older adults with early symptoms of dementia and their primary informal caregivers: a randomized clinical trial Full Text available with Trip Pro

Effectiveness of case management among older adults with early symptoms of dementia and their primary informal caregivers: a randomized clinical trial It is believed that timely recognition and diagnosis of dementia is a pre-condition for improving care for both older adults with dementia and their informal caregivers. However, diagnosing dementia often occurs late in the disease. This means that a significant number of patients with early symptoms of dementia and their informal caregivers may (...) lack appropriate care.To compare the effects of case management and usual care among community-dwelling older adults with early symptoms of dementia and their primary informal caregivers.Randomized controlled trial with measurements at baseline and after 6 and 12 months.Primary care in West-Friesland, the Netherlands.99 pairs of community-dwelling older adults with dementia symptoms (defined as abnormal screening for symptoms of dementia) and their primary informal caregivers.12 months of case

2011 EvidenceUpdates Controlled trial quality: uncertain

405. Sleep-disordered breathing, hypoxia, and risk of mild cognitive impairment and dementia in older women. Full Text available with Trip Pro

Sleep-disordered breathing, hypoxia, and risk of mild cognitive impairment and dementia in older women. Sleep-disordered breathing (characterized by recurrent arousals from sleep and intermittent hypoxemia) is common among older adults. Cross-sectional studies have linked sleep-disordered breathing to poor cognition; however, it remains unclear whether sleep-disordered breathing precedes cognitive impairment in older adults.To determine the prospective relationship between sleep-disordered (...) breathing and cognitive impairment and to investigate potential mechanisms of this association.Prospective sleep and cognition study of 298 women without dementia (mean [SD] age: 82.3 [3.2] years) who had overnight polysomnography measured between January 2002 and April 2004 in a substudy of the Study of Osteoporotic Fractures. Sleep-disordered breathing was defined as an apnea-hypopnea index of 15 or more events per hour of sleep. Multivariate logistic regression was used to determine the independent

2011 JAMA

406. Randomized controlled trial of a dementia care programme for families of home-resided older people with dementia (Abstract)

Randomized controlled trial of a dementia care programme for families of home-resided older people with dementia This paper reports a study to examine the effectiveness of a 6-month dementia care programme for Chinese families living with and caring for a relative with dementia, compared with routine family support services in Hong Kong.Recognizing the adverse psychosocial health effects inherent in dementia care, different psychosocial interventions provided preliminary evidence (...) of their effectiveness in improving family members' knowledge and skills in caregiving and delaying dementia sufferers' illness deterioration and institutionalization. Little is known about the effects of such interventions for family caregivers' psychosocial health conditions, particularly in non-Western populations.A randomized controlled trial was conducted with 92 Chinese families of a relative with dementia in two dementia care centres in Hong Kong. They were randomly selected from a dementia client list

2011 EvidenceUpdates Controlled trial quality: uncertain

407. CSF amyloid beta38 as a novel diagnostic marker for dementia with Lewy bodies Full Text available with Trip Pro

CSF amyloid beta38 as a novel diagnostic marker for dementia with Lewy bodies The clinical distinction between Alzheimer's disease (AD) and dementia with Lewy bodies (DLB) is sometimes difficult, particularly in mild cases. Although CSF markers such as amyloid β42 (Aβ42) and P-tau can distinguish between AD and normal controls, their ability to distinguish between AD and DLB is not adequate.This study aims to investigate whether CSF markers, in particular levels of Aβ38, can differentiate (...) between mild AD and DLB.85 individuals were included after standardised diagnostic procedures: 30 diagnosed as probable AD, 23 probable DLB, 20 probable Parkinson's disease dementia and 12 non-demented control subjects. CSF levels of Aβ38, Aβ40 and Aβ42 were determined using commercially available ultra-sensitive multi-array kit assay (MSD) for human Aβ peptides. Total tau (T-tau) and phosphorylated tau (P-tau) were analysed using ELISA (Innotest). In addition, combinations (Aβ42/Aβ38, Aβ42/Aβ40, Aβ42

2011 EvidenceUpdates

408. Cerebrospinal fluid biomarkers in the differential diagnosis of Alzheimer`s disease from other cortical dementias Full Text available with Trip Pro

Cerebrospinal fluid biomarkers in the differential diagnosis of Alzheimer`s disease from other cortical dementias Considering that most semantic dementia (SD) and frontotemporal dementia (FTD) patients show no post-mortem Alzheimer's disease (AD) pathology, cerebrospinal fluid (CSF) biomarkers may be of value for distinguishing these patients from those with AD. Additionally, biomarkers may be useful for identifying patients with atypical phenotypic presentations of AD, such as posterior

2011 EvidenceUpdates

409. Quetiapine for the treatment of behavioural and psychological symptoms of dementia (BPSD): a meta-analysis of randomised placebo-controlled trials

Quetiapine for the treatment of behavioural and psychological symptoms of dementia (BPSD): a meta-analysis of randomised placebo-controlled trials Quetiapine for the treatment of behavioural and psychological symptoms of dementia (BPSD): a meta-analysis of randomised placebo-controlled trials Quetiapine for the treatment of behavioural and psychological symptoms of dementia (BPSD): a meta-analysis of randomised placebo-controlled trials Cheung G, Stapelberg J CRD summary The authors concluded (...) that, using the Neuropsychiatric Inventory and the Clinical Global Impression of Change scale,quetiapine was statistically more effective than placebo for the behavioural and psychological symptoms of dementia in elderly people; the clinical significance of the effects was questionable. Limitations to the review methods mean that the reliability of the authors' conclusion is unclear. Authors' objectives To evaluate the efficacy of quetiapine for the behavioural and psychological symptoms of dementia

2011 DARE.

410. Cognitive and memory training in adults at risk of dementia: a systematic review

Cognitive and memory training in adults at risk of dementia: a systematic review Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2011 DARE.

411. A systematic review of the effects of physical activity on physical functioning, quality of life and depression in older people with dementia

A systematic review of the effects of physical activity on physical functioning, quality of life and depression in older people with dementia Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2011 DARE.

412. The association of antihypertensive medication use with risk of cognitive decline and dementia: a meta-analysis of longitudinal studies

The association of antihypertensive medication use with risk of cognitive decline and dementia: a meta-analysis of longitudinal studies Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2011 DARE.

413. Review: in people with dementia, cholinesterase inhibitors may increase syncope and memantine may reduce fractures

Review: in people with dementia, cholinesterase inhibitors may increase syncope and memantine may reduce fractures Review: in people with dementia, cholinesterase inhibitors may increase syncope and memantine may reduce fractures | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username (...) and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: in people with dementia, cholinesterase inhibitors may increase syncope and memantine may reduce fractures Article Text Therapeutics Review: in people

2011 Evidence-Based Mental Health

414. Non-Pharmacological Interventions for Behavioral Symptoms of Dementia

Non-Pharmacological Interventions for Behavioral Symptoms of Dementia Management Briefs Enter search terms Button to search HSRD ® Inside VA Budget and Performance Inside the News Room National Observances Special Events » » » » » Management Briefs Health Services Research & Development Management Briefs Management eBriefs: Provide VA senior managers with results from VA Health Services Research in a concise and timely manner. , April 2019, Issue 152 , March 2019, Issue 151 , March 2019, Issue

2011 Veterans Affairs - R&D

415. Caregiver support groups in patients with dementia: a meta-analysis

Caregiver support groups in patients with dementia: a meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2011 DARE.

416. Cross-sectional study: The organisational culture of nursing staff providing long-term dementia care is related to quality of care Full Text available with Trip Pro

Cross-sectional study: The organisational culture of nursing staff providing long-term dementia care is related to quality of care The organisational culture of nursing staff providing long-term dementia care is related to quality of care | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your (...) username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here The organisational culture of nursing staff providing long-term dementia care is related to quality of care Article Text Nursing Issues Cross-sectional

2011 Evidence-Based Nursing

417. Efficacy and tolerability of antidepressants in the treatment of behavioral and psychological symptoms of dementia: a literature review of evidence Full Text available with Trip Pro

Efficacy and tolerability of antidepressants in the treatment of behavioral and psychological symptoms of dementia: a literature review of evidence Efficacy and tolerability of antidepressants in the treatment of behavioral and psychological symptoms of dementia: a literature review of evidence Efficacy and tolerability of antidepressants in the treatment of behavioral and psychological symptoms of dementia: a literature review of evidence Henry G, Williamson D, Tampi RR CRD summary The review (...) found that antidepressants can be an effective treatment for behavioural and psychological symptoms of dementia in elderly demented patients and were usually well tolerated. Limitations in the review, which included failure to assess study quality, differences between the studies and a lack of predefined outcome measures in the review, mean that the authors’ conclusions require cautious interpretation. Authors' objectives To evaluate the efficacy and tolerability of antidepressants for treating

2011 DARE.

418. Survey: Most hospices and palliative care programmes in the USA serve people with dementia; lack of awareness, need for respite care and reimbursement policies are the main barriers to providing this care

Survey: Most hospices and palliative care programmes in the USA serve people with dementia; lack of awareness, need for respite care and reimbursement policies are the main barriers to providing this care Most hospices and palliative care programmes in the USA serve people with dementia; lack of awareness, need for respite care and reimbursement policies are the main barriers to providing this care | Evidence-Based Nursing We use cookies to improve our service and to tailor our content (...) are here Most hospices and palliative care programmes in the USA serve people with dementia; lack of awareness, need for respite care and reimbursement policies are the main barriers to providing this care Article Text Care of the older person Survey Most hospices and palliative care programmes in the USA serve people with dementia; lack of awareness, need for respite care and reimbursement policies are the main barriers to providing this care Tony Ryan 1 , Christine Ingleton 1 Statistics from

2011 Evidence-Based Nursing

419. Randomised controlled trial: Home-based biobehavioural intervention reduces dependence, increases engagement of patients with dementia in the short term and improves care giver well-being and confidence

Randomised controlled trial: Home-based biobehavioural intervention reduces dependence, increases engagement of patients with dementia in the short term and improves care giver well-being and confidence Home-based biobehavioural intervention reduces dependence, increases engagement of patients with dementia in the short term and improves care giver well-being and confidence | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can (...) biobehavioural intervention reduces dependence, increases engagement of patients with dementia in the short term and improves care giver well-being and confidence Article Text Care of the older person Randomised controlled trial Home-based biobehavioural intervention reduces dependence, increases engagement of patients with dementia in the short term and improves care giver well-being and confidence Debra J Hain Statistics from Altmetric.com Commentary on: Gitlin LN , Winter L , Dennis MP , et al

2011 Evidence-Based Nursing

420. Non-pharmacological Interventions for Behavioral Symptoms of Dementia

Non-pharmacological Interventions for Behavioral Symptoms of Dementia Evidence-based Synthesis Program Department of Veterans Affairs Health Services Research & Development Service Investigators: Principal Investigator: Maya E. O’Neil, PhD Co-Investigators: Michele Freeman, MPH Vivian Christensen, PhD Robin Telerant, MD Ashlee Addleman, MPH Devan Kansagara, MD, MCR Prepared for: Department of Veterans Affairs Veterans Health Administration Health Services Research & Development Service (...) Washington, DC 20420 Prepared by: Evidence-based Synthesis Program (ESP) Center Portland VA Medical Center Portland, OR Devan Kansagara, MD, MCR, Director A Systematic Evidence Review of Non-pharmacological Interventions for Behavioral Symptoms of Dementia March 2011i Non-pharmacological Interventions for Behavioral Symptoms of Dementia Evidence-based Synthesis Program This report is based on research conducted by the Evidence-based Synthesis Pro- gram (ESP) Center located at the Portland VA Medical

2011 Veterans Affairs Evidence-based Synthesis Program Reports